Used primarily in pharmaceutical research and development, this compound serves as a key intermediate in the synthesis of biologically active molecules, particularly immunomodulatory drugs. It plays a significant role in the production of analogs related to thalidomide and lenalidomide, which are employed in the treatment of multiple myeloma and other hematological cancers. Its structure supports the modulation of cytokine activity and inhibition of tumor angiogenesis. Additionally, it is utilized in the design of novel therapeutic agents targeting inflammatory diseases and neoplastic conditions due to its ability to influence protein-protein interactions within cellular signaling pathways.